Further studies in homogenous groups of patients with varying degrees of obesity would be necessary to understand the effect of FTO genetic variations on systemic insulin resistance and the specific effects on bone. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.